Home: PCU
2|2003: CME Audio Series
Prostate Cancer Update: A CME Audio Series and Activity
Statement of Need/Target Audience
Prostate cancer is one of the most rapidly evolving fields in
urology. Published results from clinical trials lead to the emergence
of new surgical and radiation therapy techniques and therapeutic
agents, along with changes in the indications for existing treatments.
In order to offer optimal patient care — including the option
of clinical trial participation — the practicing urologist
and radiation oncologist must be well informed of these advances.
To bridge the gap between research and patient care, Prostate Cancer
Update utilizes one-on-one discussions with leading urologic oncology
investigators. By providing access to the latest research developments
and expert perspectives, this CME program assists urologists and
radiation oncologists in the formulation of up-to-date clinical
management strategies.
Global Learning Objectives
Upon completion of this activity, participants should be able
to:
- Critically evaluate the clinical implications of emerging clinical
trial data in prostate cancer treatment.
- Inform patients about the specific risks and benefits of local
and systemic therapies.
- Provide individualized counseling to patients regarding the
choice and timing of endocrine therapy.
- Offer patients information regarding their prognosis with and
without various therapeutic options.
Issue 2, 2003 of Prostate Cancer Update consists of discussions
with three research leaders on a variety of important issues, including
timing and duration of total androgen blockade, PSA relapse, brachytherapy
and several interesting case discussions.
Specific Learning Objectives for Issue 2
Upon completion of this activity, participants should be able
to:
- Counsel patients about timing and duration of endocrine therapy
based on currently available data.
- Describe the relative risks and benefits of total androgen
blockade in the adjuvant and advanced disease setting.
- Describe and implement a treatment algorithm for patients with
elevated PSA after radical prostatectomy.
- Counsel patients about the risks and benefits of brachytherapy
versus external beam radiation.
Accreditation Statement
This activity has been planned and implemented in accordance with
the Essential Areas and Policies of the Accreditation Council for
Continuing Medical Education (ACCME) through the joint sponsorship
of the Postgraduate Institute for Medicine and NL Communications,
Inc. The Postgraduate Institute for Medicine is accredited by the
ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Postgraduate Institute for Medicine designates this educational
activity for a maximum of 3 category 1 credits toward the AMA Physician's
Recognition Award. Each physician should claim only credits that
he/she actually spent in the activity.
|
